Tracked deals
6
6 tracked deals across 2021-2025.
Operating Company
Healthcare
BioIVT
Woodbury, New York, United States
BioIVT (formerly BioreclamationIVT) is a leading global provider of high-quality biological specimens and value-added research services. It specializes in control and disease-state samples (human and animal tissues, cell products, blood and other biofluids), in vitro hepatic modeling, and ADME-Tox model systems.
- Focus Areas
- Biospecimen sourcing and procurement, ADME-Tox model systems and in vitro hepatic modeling, Biorepository / biobanking
- Website
- bioivt.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
5 buyout · 1 divestiture
BioIVT Acquisition Volume by Year
Last 5 years
Supporting Data
Recent Transactions
-
November 4, 2025
- Buyer
- BioIVT
- Target
- BeCytes Biotechnologies
- Industry
- Biotechnology
- Location
- Catalonia, Spain
- Type
- Buyout
BioIVT has acquired BeCytes Biotechnologies, a Barcelona-based provider of ethically sourced human tissues and primary cell isolation services. The deal expands BioIVT's European footprint and strengthens its capabilities for New Approach Methodologies (NAMs) and ADME research; BeCytes will continue to operate from Barcelona and financial terms were not disclosed.
-
August 21, 2024
- Buyer
- BioIVT
- Target
- ZenBio Inc.
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Type
- Buyout
BioIVT has acquired ZenBio, a Durham-based provider of advanced cell products and biospecimen services, to expand its skin-based expertise, primary cell and exosome isolation capabilities, and blood product offerings for pharmaceutical and cosmetics research. The deal strengthens BioIVT's service portfolio and complements recent integrations to accelerate support for drug discovery and cosmeceutical development; financial terms were not disclosed.
-
July 18, 2023
- Buyer
- BioIVT
- Target
- PrecisionMed, LLC
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Buyout
BioIVT, a global biospecimen solutions provider, has acquired PrecisionMed, LLC, a Carlsbad-based supplier of high-quality human biospecimens and owner of a large longitudinal cerebrospinal fluid (CSF) repository. The acquisition expands BioIVT's supply network, inventory and capacity for CSF and liquid biopsy products while PrecisionMed will continue to operate from its existing headquarters and collection sites.
-
September 12, 2022
- Buyer
- BioIVT
- Target
- XenoTech
- Seller
- Sekisui Chemical
- Industry
- Biotechnology
- Location
- Kansas, United States
- Type
- Divestiture
BioIVT has acquired XenoTech, a Kansas City–based provider of ADME‑Tox in vitro models and contract research services, from Sekisui Chemical. The acquisition expands BioIVT's hepatic product portfolio and ADME/DMPK capabilities to better support biopharma customers' preclinical testing needs. Financial terms were not disclosed.
-
April 4, 2022
- Buyer
- BioIVT
- Target
- Tennessee Blood Services
- Seller
- Harold Stamey, Robert Stamey, Steve Stamey, Chris Stamey
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Type
- Buyout
BioIVT acquired Tennessee Blood Services (TBS), a commercial blood bank and donor center based in Memphis, Tennessee. The acquisition expands BioIVT’s donor network and increases its capacity and control over fresh whole blood, plasma, serum and red blood cell supplies for drug and diagnostic development; financial terms were not disclosed.
-
June 28, 2021
- Buyer
- BioIVT
- Target
- Valley Biomedical Products & Services, Inc.
- Industry
- Medical Devices
- Location
- Virginia, United States
- Type
- Buyout
BioIVT, a provider of research models and value-added research services, has acquired Valley Biomedical Products & Services, an FDA-registered manufacturer of in vitro diagnostics, sera, plasma and reagents based in Winchester, Virginia. The acquisition will expand BioIVT’s capabilities in IVD manufacturing and cell & gene therapy support by combining Valley Biomedical’s reagent and blood-product manufacturing with BioIVT’s donor centers and specimen services; BioIVT will continue operating the Winchester facility and retain its staff.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
3 tracked deals by BioIVT.
Biotechnology Buyers & Acquisitions
2 tracked deals by BioIVT.
Medical Devices Buyers & Acquisitions
1 tracked deal by BioIVT.
Acquisitions in California
1 tracked deal by BioIVT.
Acquisitions in Kansas
1 tracked deal by BioIVT.
Acquisitions in North Carolina
1 tracked deal by BioIVT.
Acquisitions in Tennessee
1 tracked deal by BioIVT.
Selling a company? Get in front of buyers like BioIVT
Turn tracked acquisition activity into an outreach-ready buyer list.